- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Sunquest posts loss despite strong growth
Sunquest posts loss despite strong growthTucson, AZ-based Sunquest Information Systems reported a 25% increase in revenue for its third quarter. Despite healthy revenue growth, however, earnings before write-offs were below analysts'
Sunquest posts loss despite strong growth
Tucson, AZ-based Sunquest Information Systems reported a 25% increase in revenue for its third quarter. Despite healthy revenue growth, however, earnings before write-offs were below analysts' expectations.
For the third quarter (end-September), Sunquest had revenues of $24.3 million, compared with $19.3 million for the same period in 1996. The company reported a net loss after write-offs of $268,000, compared with a net income of $1.7 million for the third quarter in 1996.
Sunquest had two sizable write-offs in the quarter: $1.3 million for in-process technology acquired in connection with the purchase of the PreciseCare Medication Management System from Medintell Systems and $1.5 million for previously capitalized software development costs relating to Sunquest's IntelliCarer suite of products.
The primary reason the company failed to meet analysts' expectations for earnings before write-offs was delays in customer installation schedules and the resultant delays in revenue recognition, said Dr. Sidney Goldblatt, president and CEO. The company is taking steps to mitigate these delays by increasing staff in certain areas such as interfacing, customer training, and targeted consulting.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
